RMD Form 144 Reveals 3,000-Share Proposed Sale, Prior 9,883 Shares Sold

Rhea-AI Filing Summary

Form 144 notice for ResMed Inc. (RMD) shows proposed sales of common stock by an individual affiliated with the issuer. The filing lists a broker (Fidelity Brokerage Services) and an intended sale of 3,000 shares with an aggregate market value of $823,080 to be sold on 10/01/2025 on the NYSE. The filer acquired 1,000 shares on 11/11/2022 by restricted stock vesting (compensation) and 2,000 shares on 10/01/2025 via option exercise (options granted 11/14/2018) with cash payment. The form also discloses sales by the same person totaling 9,883 shares in the prior three months with gross proceeds reported for each sale.

Insights

Securities Analyst

TL;DR: Insider proposes modest sale of 3,000 shares; prior three-month sales total 9,883 shares, representing a de minimis stake relative to outstanding shares.

The filing identifies a scheduled sale through Fidelity of 3,000 ResMed common shares valued at $823,080, with prior disposals of 3,883, 3,000, and 3,000 shares in July, August, and September 2025 respectively. The filing documents acquisition types (restricted stock vesting and option exercise) and notes cash payment for the option exercise. Given the issuer's reported outstanding share count of 146,414,839, these transactions are a very small fraction of total shares outstanding and appear routine rather than company-changing.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 requirements; seller certifies lack of undisclosed material nonpublic information.

The form includes the standard attestation that the seller is not aware of material undisclosed information and provides acquisition history for the securities offered for sale. The use of a broker and explicit listing of acquisition dates and nature (vesting and option exercise) align with compliance expectations. No additional governance matters or atypical arrangements are disclosed in the filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3000	823080.00	146414839	10/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/11/2022	Restricted Stock Vesting	Issuer			1000	11/11/2022	Compensation
Common	10/01/2025	Options Granted - 11/14/2018	Issuer			2000	10/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brett Sandercock 9001 Spectrum Center Blvd. San Diego CA 92123	Common	07/01/2025	3883	997892.17
Brett Sandercock 9001 Spectrum Center Blvd. San Diego CA 92123	Common	08/01/2025	3000	845700.00
Brett Sandercock 9001 Spectrum Center Blvd. San Diego CA 92123	Common	09/02/2025	3000	812310.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for ResMed (RMD) disclose?

The notice discloses a proposed sale of 3,000 common shares through Fidelity on 10/01/2025 with aggregate market value $823,080 and prior three-month sales totaling 9,883 shares.

Who acquired the securities being sold and how were they acquired?

The filing shows acquisition of 1,000 shares on 11/11/2022 by restricted stock vesting (compensation) and 2,000 shares on 10/01/2025 via option exercise (options originally granted 11/14/2018), paid in cash.

Which broker is handling the proposed sale in the Form 144?

The broker listed is Fidelity Brokerage Services LLC, address shown as 900 Salem Street, Smithfield, RI, and the intended exchange is the NYSE.

How significant are these insider sales relative to ResMed's outstanding shares?

The filing reports 146,414,839 shares outstanding; the proposed 3,000-share sale and recent disposals total 9,883 shares, a very small fraction of outstanding shares.

Does the filer assert they possess any undisclosed material information?

By signing the notice, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.